Buy & Sell Recursion Pharmaceuticals Inc (RXRX) – Recursion Pharmaceuticals Inc Price Today
Key Stats
- $1.69BMarket Cap
- HealthSector
- -42.74%3M Drawdown
- $1.02BEnterprise Value
- -Dividend Yield
- 13 daysTypical Hold Time
Recursion Pharmaceuticals Inc (RXRX) is currently valued at a market capitalization of $1.69B, with an enterprise value of $1.02B. Over the past 52 weeks, Recursion Pharmaceuticals Inc has traded between a low of $2.84 and a high of $6.79, highlighting its annual price range. Over the past three months, Recursion Pharmaceuticals Inc has recorded a drawdown of -42.74%, reflecting recent price volatility. Recursion Pharmaceuticals Inc offers a dividend yield of -. On average, investors hold Recursion Pharmaceuticals Inc for approximately 13 days, indicating typical investor behavior on the platform.
About Recursion Pharmaceuticals Inc
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company leveraging artificial intelligence (AI) and machine learning to industrialize drug discovery. The company's unique approach combines one of the world's largest biological and chemical datasets with automated wet-lab and computational systems to map human biology and identify potential therapeutic candidates across a range of diseases, including oncology and rare diseases. Recursion aims to accelerate the traditionally slow and expensive process of drug development.
